Vitamin D Reverts the Exosome-Mediated Transfer of Cancer Resistance to the mTOR Inhibitor Everolimus in Hepatocellular Carcinoma

Several multi-kinase inhibitors were widely tested as potential first-line or second-line therapy in patients with advanced hepatocellular carcinoma (HCC). However, acquired drug resistance limits their clinical efficacy. Exosomes are microvesicles secreted by tumor and stromal cells that participat...

Descripción completa

Detalles Bibliográficos
Autores principales: Negri, Mariarosaria, Amatrudo, Feliciana, Gentile, Annalisa, Patalano, Roberta, Montò, Tatiana, de Angelis, Cristina, Simeoli, Chiara, Pirchio, Rosa, Auriemma, Renata Simona, Colao, Annamaria, Pivonello, Rosario, Pivonello, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083073/
https://www.ncbi.nlm.nih.gov/pubmed/35547877
http://dx.doi.org/10.3389/fonc.2022.874091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9083073/
https://www.ncbi.nlm.nih.gov/pubmed/35547877
http://dx.doi.org/10.3389/fonc.2022.874091

Ejemplares similares